Search by Drug Name or NDC

    NDC 58914-0601-21 Pylera 140; 125; 125 mg/1; mg/1; mg/1 Details

    Pylera 140; 125; 125 mg/1; mg/1; mg/1

    Pylera is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE.

    Product Information

    NDC 58914-0601
    Product ID 58914-601_3d322704-6e38-4d2e-a481-f417a711676b
    Associated GPIs 49992003150120
    GCN Sequence Number 062462
    GCN Sequence Number Description bismuth/metronid/tetracycline CAPSULE 125-125 MG ORAL
    HIC3 D4F
    HIC3 Description ANTI-ULCER-H.PYLORI AGENTS
    GCN 98238
    HICL Sequence Number 020019
    HICL Sequence Number Description COLLOIDAL BISMUTH SUBCITRATE/METRONIDAZOLE/TETRACYCLINE HCL
    Brand/Generic Brand
    Proprietary Name Pylera
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 140; 125; 125
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050786
    Listing Certified Through 2024-12-31

    Package

    NDC 58914-0601-21 (58914060121)

    NDC Package Code 58914-601-21
    Billing NDC 58914060121
    Package 1 BOTTLE in 1 BOX (58914-601-21) / 120 CAPSULE in 1 BOTTLE
    Marketing Start Date 2013-08-01
    NDC Exclude Flag N
    Pricing Information N/A